Search Results for: LCK

148 interactions involving LCK - LCK proto-oncogene, Src family tyrosine kinase found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
UBE3A ubiquitin protein ligase E3A
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Prader-Willi and Angelman syndromes, including: Angelman syndrome (AS); Prader-Willi syndrome (PWS)
UHRF2 ubiquitin like with PHD and ring finger domains 2
  • SUMOylation of transcription cofactors
ACP1 acid phosphatase 1
  • Adenine
  • 4-Nitrophenyl Phosphate
C1QTNF2 C1q and TNF related 2
CD247 CD247 molecule
  • Muromonab
CD5 CD5 molecule
CTDSP1 CTD small phosphatase 1
  • Aspartate beryllium trifluoride
  • Citric acid
CTNND2 catenin delta 2
  • Cri du chat syndrome; Cat cry syndrome; Chromosme 5p deletion syndrome
DEF6 DEF6 guanine nucleotide exchange factor
ERBB3 erb-b2 receptor tyrosine kinase 3
  • Tucatinib
  • Lethal congenital contractural syndrome (LCCS)
  • Type I diabetes mellitus
ERBB4 erb-b2 receptor tyrosine kinase 4
  • Afatinib
  • Fostamatinib
  • Brigatinib
  • Zanubrutinib
FAM166B family with sequence similarity 166 member B
FAM174A family with sequence similarity 174 member A
G3BP1 G3BP stress granule assembly factor 1
LAX1 lymphocyte transmembrane adaptor 1
LIME1 Lck interacting transmembrane adaptor 1
LZTS2 leucine zipper tumor suppressor 2
MS4A1 membrane spanning 4-domains A1
  • Rituximab
  • Ibritumomab tiuxetan
  • Tositumomab
  • Ofatumumab
  • Obinutuzumab
  • Technetium Tc-99m nofetumomab merpentan
  • Ocrelizumab
NEDD9 neural precursor cell expressed, developmentally down-regulated 9
NFKBID NFKB inhibitor delta

Page 7 out of 8 pages